Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA–IIIA non-small-cell lung cancer

被引：4
|
作者：
Masafumi Kawamura
Keisuke Eguchi
Yotaro Izumi
Yasushi Yamato
Teruaki Koike
Hirozo Sakaguchi
Enjo Hada
Koichi Kobayashi
机构：
[1] Keio University Hospital,Division of General Thoracic Surgery
[2] Niigata Prefectural Cancer Center Hospital,undefined
[3] Mitsui Memorial Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷
关键词：
Non-platinum doublet; Adjuvant chemotherapy; Non-small-cell lung cancer; Docetaxel; Gemcitabin; Surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：495 / 501
页数：6
相关论文
共 50 条
  • [41] Combination of docetaxel and gemcitabine effective in non-small-cell lung cancer
    不详
    ONCOLOGY-NEW YORK, 2001, 15 (02): : 186 - 186
  • [42] Management of non-small-cell lung cancer (stage IIIa)
    Gridelli, C
    Rossi, A
    Guerriero, C
    Ferrara, C
    Del Gaizo, F
    Colantuoni, G
    Salerno, V
    Nicolella, D
    TUMORI JOURNAL, 2003, : S103 - S105
  • [43] S-1 vs. paclitaxel plus carboplatin as adjuvant chemotherapy for completely resected stage II/IIIA non-small-cell lung cancer
    Okuda, Katsuhiro
    Yano, Motoki
    Tatematsu, Tsutomu
    Nakamae, Katsumi
    Yamada, Takeshi
    Kasugai, Toshio
    Nishida, Tsutomu
    Sano, Masaaki
    Moriyama, Satoru
    Haneda, Hiroshi
    Kawano, Osamu
    Nakanishi, Ryoichi
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 8 (01) : 73 - 79
  • [44] Phase I/II trial of docetaxel and carboplatin as a first-line therapy in patients with stage IV non-small-cell lung cancer
    Kataoka, Kensuke
    Suzuki, Ryujiro
    Taniguchi, Hiroyuki
    Noda, Yasunobu
    Shindoh, Joe
    Matsumoto, Syuichi
    Watanabe, Yoshiaki
    Honda, Kousuke
    Suzuki, Kiyoshi
    Baba, Kenji
    Imaizumi, Kazuyoshi
    Kume, Hiroaki
    Hasegawa, Yoshinori
    Takagi, Kenzo
    LUNG, 2006, 184 (03) : 133 - 139
  • [45] Phase I/II Trial of Docetaxel and Carboplatin as a First-Line Therapy in Patients with Stage IV Non-Small-Cell Lung Cancer
    Kensuke Kataoka
    Ryujiro Suzuki
    Hiroyuki Taniguchi
    Yasunobu Noda
    Joe Shindoh
    Syuichi Matsumoto
    Yoshiaki Watanabe
    Kousuke Honda
    Kiyoshi Suzuki
    Kenji Baba
    Kazuyoshi Imaizumi
    Hiroaki Kume
    Yoshinori Hasegawa
    Kenzo Takagi
    Lung, 2006, 184 : 133 - 139
  • [46] Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer
    Wang, Lin Run
    Huang, Ming Zhu
    Zhang, Guo Bing
    Xu, Nong
    Wu, Xiu Hua
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (04) : 601 - 607
  • [47] Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer
    Lin Run Wang
    Ming Zhu Huang
    Guo Bing Zhang
    Nong Xu
    Xiu Hua Wu
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 601 - 607
  • [48] Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)
    Valerie Israel
    Scott T. Tagawa
    Terry Snyder
    Susan Jeffers
    Derek Raghavan
    Investigational New Drugs, 2004, 22 : 291 - 297
  • [49] Phase I/II trial of docetaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer
    Shoji A.
    Ogura T.
    Suzuki K.
    Takahashi H.
    Takahashi K.
    Yoshiike Y.
    Watanuki Y.
    Nishiyama H.
    Toda M.
    Odagiri S.
    International Journal of Clinical Oncology, 2000, 5 (5) : 323 - 327
  • [50] Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline
    Okawara, G
    Ung, YC
    Markman, BR
    Mackay, JA
    Evans, WK
    LUNG CANCER, 2004, 44 (01) : 1 - 11
12345